Financial Performance - Chengdu Sicrory Microelectronics Co., Ltd. reported a significant increase in revenue for the first half of 2023, achieving a total revenue of RMB 500 million, representing a year-on-year growth of 25%[1]. - The company’s net profit for the same period reached RMB 100 million, marking a 30% increase compared to the previous year[1]. - The company's operating revenue for the first half of 2023 was ¥110,472,068.86, a decrease of 15.05% compared to ¥130,049,747.60 in the same period last year[22]. - The net profit attributable to shareholders for the first half of 2023 was ¥38,940,765.25, down 31.18% from ¥56,584,454.82 in the previous year[22]. - The gross profit margin decreased from 72.37% in H1 2022 to 56.59% in H1 2023, indicating a significant decline in profitability[94]. - Operating costs increased by 33.45% to CNY 47.96 million, primarily due to the addition of testing equipment and personnel[99]. - The net cash flow from operating activities increased by 643.85% to ¥15,807,743.92, compared to ¥2,125,135.95 in the same period last year[23]. Market Expansion and Product Development - User data indicates that the number of active users of the company's products has grown to 1 million, an increase of 15% from the previous half-year[1]. - The company has outlined its future outlook, projecting a revenue growth of 20% for the second half of 2023, driven by new product launches and market expansion efforts[1]. - New product development includes the introduction of a next-generation semiconductor chip, expected to enhance performance by 40% over previous models[1]. - The company is actively pursuing market expansion, targeting an increase in market share by 10% in the Asia-Pacific region by the end of 2023[1]. - The company is expanding its market presence in Southeast Asia, targeting a 15% market share by the end of 2024[136]. - New product launches contributed to 40% of total sales, with the introduction of two innovative microchips that have received positive market feedback[135]. Research and Development - The R&D expenditure as a percentage of operating revenue increased to 10.51%, up from 8.90% in the previous year, indicating a focus on innovation[24]. - The total R&D investment for the period was approximately ¥11.61 million, representing 10.51% of operating revenue, an increase of 1.61 percentage points compared to the previous year[78]. - The company has developed over 32,000 testing programs as of June 30, 2023, including more than 27,000 self-developed programs and over 3,000 equipment matching programs[61]. - The company is conducting research on a high-power DC/DC chip reliability testing method, with a total investment of ¥5.6 million and cumulative investment of ¥1.3 million[81]. Risk Management - The management has identified potential risks, including supply chain disruptions and market competition, and is taking measures to mitigate these risks[1]. - The company attributed the decline in revenue to adjustments in order demand from clients in the military market and rising operating costs due to increased testing equipment and personnel[25]. - The company is facing risks related to talent retention and management complexity due to rapid business expansion[93]. - The company is exposed to increased competition in the military electronic component reliability testing sector, which may impact market share[93]. Corporate Governance and Shareholder Relations - The board has approved a profit distribution plan, with no plans for capital increase through reserves during this reporting period[1]. - The company reported no profit distribution or capital reserve fund transfer plans for the first half of 2023, with no dividends or bonus shares proposed[119]. - The company has undergone a change in its board and supervisory committee members, with new elections held[117]. - The company will ensure that any share reduction plans are in accordance with the Shanghai Stock Exchange rules[151]. Environmental and Social Responsibility - The company reported an investment of 0.7 million yuan in environmental protection during the reporting period[123]. - The company has established an ISO14001 environmental management system to enhance environmental awareness among employees[125]. - The company is committed to sustainable development and adheres to relevant environmental laws and regulations[125]. Strategic Acquisitions - Chengdu Sicrory is exploring potential mergers and acquisitions to enhance its technological capabilities and market presence, with a focus on companies in the semiconductor sector[1]. - The company has completed a strategic acquisition of a smaller tech firm for 200 million yuan to enhance its product offerings[134].

中国银河证券股份有限公司 关于成都思科瑞微电子股份有限公司 使用暂时闲置募集资金进行现金管理的核查意见 中国银河证券股份有限公司（以下简称"银河证券"或"保荐机构"）作为成都 思科瑞微电子股份有限公司（以下简称"思科瑞"或"公司"）首次公开发行股票并 在科创板上市及进行持续督导的保荐机构，根据《上市公司监管指引第 2 号—— 上市公司募集资金管理和使用的监管要求（2022 年修订）》、《上海证券交易 所科创板股票上市规则》和《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等有关法律法规和规范性文件的要求，对思科瑞拟使用暂时闲 置募集资金进行现金管理事项进行了核查，并发表核查意见如下： 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意成都思科瑞微电子股份有限公司首 次公开发行股票注册的批复》（证监许可〔2022〕1115 号），同意公司首次公 开发行股票的注册申请，并经上海证券交易所同意，公司首次向社会公众公开发 行人民币普通股（A 股）股票 2,500.00 万股，发行价格为每股人民币 55.53 元， 募集资金总额为人民币 138,825.00 万元，扣除各项发行费用（不含增值税 ...

证券代码：688053 证券简称：思科瑞 公告编号：2023-047 成都思科瑞微电子股份有限公司 关于召开 2023 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 会议召开时间：2023 年 09 月 01 日(星期五) 上午 10:00-11:00 会议召开地点：上海证券交易所上证路演中心（网址： https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2023 年 08 月 25 日(星期五) 至 08 月 31 日(星期 四)16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮 箱 security@cd-screen.cn 进行提问。公司将在说明会上对投资者普遍关注的 问题进行回答。 成都思科瑞微电子股份有限公司（以下简称"公司"）已于 2023 年 8 月 25 日发布公司 2023 年半年度报告，为便于广大投资者更全面深入地了解公司 2023 年半年度经营成果、财务状况，公司计划于 2023 ...

关于使用部分闲置募集资金进行现金管理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 成都思科瑞微电子股份有限公司（以下简称"公司"）于 2023 年 8 月 23 日召开了公司第二届董事会第二次会议、第二届监事会第二次会议，审议通 过了《关于使用部分闲置募集资金进行现金管理的议案》，同意公司在保证不 影响募集资金投资项目实施、确保募集资金安全的前提下，使用额度最高不超 过人民币 8 亿元(含本数)的闲置募集资金进行现金管理，用于购买投资安全性 高、流动性好的投资产品（包括但不限于协定性存款、结构性存款、定期存 款、大额存单、通知存款等），自公司董事会审议通过之日起 12 个月内有 效。在前述额度及期限范围内，公司可以循环滚动使用该资金。公司董事会授 权公司董事长在上述额度及决议有效期内行使投资决策权、签署相关文件等事 宜，具体事项由公司财务部负责组织实施。 一、募集资金基本情况 证券代码：688053 证券简称：思科瑞 公告编号：2023-045 根据中国证券监督管理委员会《关于同意成都思科瑞微电子股份有限公司 首 ...

中国银河证券股份有限公司 关于成都思科瑞微电子股份有限公司 使用部分超募资金回购股份的核查意见 中国银河证券股份有限公司（以下简称"银河证券"或"保荐机构"）作为成都 思科瑞微电子股份有限公司（以下简称"思科瑞"或"公司"）首次公开发行股票并 在科创板上市及进行持续督导的保荐机构，根据《证券发行上市保荐业务管理办 法（2023 年修订）》、《科创板上市公司持续监管办法（试行）》、《上海证 券交易所科创板股票上市规则》、《上海证券交易所科创板上市公司自律监管指 引第 1 号——规范运作》、《上海证券交易所上市公司自律监管指引第 7 号—— 回购股份》及《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监 管要求（2022 年修订）》等有关规定，对思科瑞使用部分超募资金回购股份的 事项进行了审慎核查，核查意见如下： 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意成都思科瑞微电子股份有限公司首 次公开发行股票注册的批复》（证监许可〔2022〕1115 号），同意公司首次公 开发行股票的注册申请，并经上海证券交易所同意，公司首次向社会公众公开发 行人民币普通股（A 股）股票 2,500.00 万 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥63,719,430.62, representing a year-on-year increase of 25.70%[5] - The net profit attributable to shareholders for the same period was ¥23,413,414.12, reflecting a growth of 24.02% compared to the previous year[5] - The net profit after deducting non-recurring gains and losses was ¥23,309,582.57, which is an increase of 30.28% year-on-year[5] - Total operating revenue for Q1 2023 reached ¥63,719,430.62, a 25.7% increase from ¥50,693,382.15 in Q1 2022[20] - Net profit for Q1 2023 was ¥23,413,414.12, representing a 24.0% increase compared to ¥18,878,213.63 in Q1 2022[21] - The total comprehensive income for Q1 2023 was ¥23,413,414.12, compared to ¥18,878,213.63 in Q1 2022[22] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥1,744,096,117.83, showing a slight increase of 0.66% from the end of the previous year[6] - Total assets as of March 31, 2023, reached CNY 1,744,096,117.83, compared to CNY 1,732,731,670.43 at the end of 2022, indicating a slight increase of approximately 0.7%[16] - Total liabilities decreased to CNY 52,932,889.67 from CNY 64,981,856.39, showing a reduction of about 18.5%[17] - The company's total equity remained stable at CNY 1,691,163,228.16 as of March 31, 2023, consistent with the previous reporting period[17] Cash Flow - The net cash flow from operating activities was ¥4,117,741.59, with an improvement attributed to better sales collection compared to the same period last year[10] - Cash inflow from operating activities in Q1 2023 was ¥57,506,250.09, compared to ¥34,535,070.13 in Q1 2022, indicating a significant increase[24] - The net cash flow from operating activities was 4,117,741.59 CNY, a significant improvement compared to -4,861,162.89 CNY in the previous period[25] - The total cash and cash equivalents at the end of the period reached 608,619,985.53 CNY, up from 167,520,107.22 CNY at the beginning of the period[26] - The net increase in cash and cash equivalents was 441,099,878.31 CNY, compared to a decrease of 17,590,688.52 CNY in the previous period[26] Research and Development - The company's R&D expenditure totaled ¥5,826,002.54, accounting for 9.14% of operating revenue, which is a decrease of 1.85 percentage points compared to the previous year[6] - Research and development expenses for Q1 2023 totaled ¥5,826,002.54, slightly up from ¥5,568,944.96 in Q1 2022[20] - The company has plans for new technology research and development to drive future growth[14] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 4,510[11] - The basic earnings per share for Q1 2023 was ¥0.23, down by 8.00% year-on-year[6] - Earnings per share for Q1 2023 were ¥0.23, down from ¥0.25 in Q1 2022[22] Strategic Focus - The company is focusing on expanding its market presence and enhancing product development strategies in the upcoming quarters[14] - The management emphasized the importance of strategic partnerships and potential acquisitions to bolster market competitiveness[14]